Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
94.05Prev. Close
94.53Volume
11,707Total traded value
0.11 CrUpper Circuit
113.26Lower Circuit
75.51Fundamentals
| Market Cap | ₹337Cr |
| ROE | 7.74% |
| P/E Ratio(TTM) | 44.11 |
| EPS(TTM) | 2.14 |
| P/B Ratio | 3.25 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.99 |
| Book Value | 29.01 |
| Debt to Equity | 0.38 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Lyka Labs
Lyka Labs is a pharmaceutical company making medicines like injections and creams for domestic and international markets, including the veterinary segment. Its business is guided by a belief in innovation and experimentation to advance its market relevance and product offerings. The company achieved a major financial turnaround, reporting a consolidated net profit of ₹811.40 lakhs against a previous year's loss.;
| Parent Organisation | Lyka Labs |
| Managing Director | Mr. Kunal Gandhi |
| NSE Symbol | LYKALABS |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.62 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.70 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.14 | ||
| Wockhardt | NA (0.00%) | -146.62 |